From: Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
Factor | HR (95% CI) | P |
---|---|---|
Base model | Â | Â |
   Age and menopausal status combined |  | 0.005 |
   Age premenopausala | 0.68 (0.55 to 0.85) |  |
   Age postmenopausala | 0.96 (0.84 to 1.09) |  |
   Post- versus premenopausal | 1.83 (1.27 to 2.46) |  |
   Tumor size |  | <0.001 |
2 cm to 5 cm versus ≤2 cm | 1.69 (1.36 to 2.10) |  |
>5 cm versus ≤2 cm | 2.31 (1.73 to 3.10) |  |
   Nodal status |  | <0.001 |
N1-3 versus N0 | 1.66 (1.30 to 2.11) | Â |
N>3 versus N0 | 2.75 (2.18 to 3.47) | Â |
   ER (positive versus negative)b | 0.87 (0.68 to 1.11) | 0.25 |
   PgR (positive versus negative)b | 0.76 (0.61 to 0.95) | 0.02 |
Additions to base model | Â | Â |
   +PMN-E (high versus low)c | 1.45 (1.10 to 1.89) | 0.01 |
   +PMN-E (continuous)d | 1.06 (0.98 to 1.14) | 0.13 |